Company / Net Debt per Share
BioAge Labs, Inc. Net Debt per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$5.27
FY2025
5-year range
-$32.24 / -$5.27
FY2023-FY2025
Trend
+83.7%
vs FY2024
Sector context
#78 of 82
Health Care
What the data says
Among 82 Health Care companies, BioAge Labs, Inc. is in the top 5% for net debt per share. Increased from $-8.04 to $-5.27 over the past 2 years.
Based on SEC 10-K filings.
-5.27 in FY2025.
Increased from $-8.04 to $-5.27 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 82This company -$5.27 Sector average $13.70
▼
-138.5% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 83.7% year-over-year.
- Ranks #78 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.27 | +83.7% |
| FY2024 | -$32.24 | -301.2% |
| FY2023 | -$8.04 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026